Company Filing History:
Years Active: 2019
Title: The Innovations of John Ohlfest
Introduction
John Ohlfest is a notable inventor based in Roseville, Minnesota. He has made significant contributions to the field of veterinary immunotherapy. His work focuses on developing innovative solutions for treating cancer in canine patients.
Latest Patents
Ohlfest holds a patent for an OX40L fusion protein aimed at the immunotherapy of tumors in veterinary animals. This patent includes an isolated recombinant polypeptide that comprises an immunoglobulin domain and a canine OX40L extracellular domain polypeptide fragment. The invention also encompasses methods for treating or alleviating cancer symptoms in canines by administering an effective amount of the isolated recombinant polypeptide or its compositions.
Career Highlights
John Ohlfest is affiliated with the University of Southern California, where he continues to advance his research in veterinary medicine. His innovative approach to immunotherapy has the potential to improve the quality of life for many canine patients suffering from cancer.
Collaborations
Ohlfest has collaborated with esteemed colleagues such as Alan L Epstein and Peisheng Hu. Their combined expertise contributes to the advancement of veterinary immunotherapy.
Conclusion
John Ohlfest's work exemplifies the intersection of innovation and veterinary medicine. His contributions are paving the way for new treatments that can significantly impact the health of canine patients.